30 Years of Evidence
Featured Content
PROSTATE cancer
Comprehensive one-day management of prostate cancer patients: PRO-FAST single-fraction ablative, urethral-sparing, HDR-like, robotic SBRT
SPINAL CANCER
Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease
BREAST CANCER
Ablative Preoperative Single-Fraction Radiation Dose Escalation Among Patients With Breast Cancer: A Phase 1 Nonrandomized Clinical Trial
Volumetric analysis of Vestibular Schwannoma after Cyberknife Stereotactic Radiosurgery/SBRT: single center study
Maris Mezeckis, Latvia | ESTRO | 2026
Anlotinib Plus Radiotherapy for Newly Diagnosed Pediatric Malignant Brainstem Gliomas: Safety and Efficacy Evaluation
Ying Wang, China | ESTRO | 2026
Cyberknife Stereotactic Radiosurgery For Vestibular Schwannoma: 9-Year Single-Centre Experience
Sandra Lediņa, Latvia | ESTRO | 2026
Dosimetric and Treatment Efficiency Comparison of IRIS versus MLC Collimators in CyberKnife Radiosurgery for Brain AVMs
Bhooshan Zade, India | ESTRO | 2026
Acoustic Neurinomas Treated with CyberKnife® SRS: Early Experience on Tolerability and Feasibility
Federica Pavoncello, Italy | ESTRO | 2026
Local control after stereotactic radiosurgery and fractionated stereotactic radiotherapy for cerebellopontine angle tumours
Łukasz Raszewsk | ESTRO | 2026
Dosimetric performance of Fixed and MLC collimators in robotic stereotactic radiosurgery for brain metastases
Anna Pederzoli, Italy | ESTRO | 2026
Optimizing Treatment Planning for Acoustic Neuromas with CyberKnife SRS: Preliminary Outcome Analysis
Federica Murtas, Italy | ESTRO | 2026
Clinical outcomes and dosimetry of root entry zone-targeted radiosurgery for trigeminal neuralgia
Bhooshan Zade | ESTRO | 2026
Radiobiological dose and treatment duration influence pain relief and sensory outcomes in CyberKnife radiosurgery for trigeminal neuralgia
Evangelos Pantelis, Greece | ESTRO | 2026
Hypofractionated Radiosurgery (25 Gy/5 fractions) for Optic Nerve Sheath Meningiomas: Results from an Exploratory Phase 2 Prospective Trial
Fariselli L, Marzoli SB, Morlino S, Pinzi V, Pedone C, De Martin E, Romeo A, Tramacere I, Marchetti M | Int J Radiat Oncol Biol Phys. | 2025
Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease
Park DJ, Lee I, Annagiri S, Chou KN, Zamarud A, Akhavan-Sigari A, Hori YS, Persad AR, Abu-Reesh D, Lam FC, Tayag A, Ustrzynski L, Emrich SC, Gu X, Pollom EL, Chang SD | Neurosurgery. | 2025
Volumetric analysis of Vestibular Schwannoma after Cyberknife Stereotactic Radiosurgery/SBRT: single center study
Maris Mezeckis, Latvia | ESTRO | 2026
Anlotinib Plus Radiotherapy for Newly Diagnosed Pediatric Malignant Brainstem Gliomas: Safety and Efficacy Evaluation
Ying Wang, China | ESTRO | 2026
Cyberknife Stereotactic Radiosurgery For Vestibular Schwannoma: 9-Year Single-Centre Experience
Sandra Lediņa, Latvia | ESTRO | 2026
Dosimetric and Treatment Efficiency Comparison of IRIS versus MLC Collimators in CyberKnife Radiosurgery for Brain AVMs
Bhooshan Zade, India | ESTRO | 2026
Acoustic Neurinomas Treated with CyberKnife® SRS: Early Experience on Tolerability and Feasibility
Federica Pavoncello, Italy | ESTRO | 2026
Local control after stereotactic radiosurgery and fractionated stereotactic radiotherapy for cerebellopontine angle tumours
Łukasz Raszewsk | ESTRO | 2026
Dosimetric performance of Fixed and MLC collimators in robotic stereotactic radiosurgery for brain metastases
Anna Pederzoli, Italy | ESTRO | 2026